Cardiac stress-rest single-photon emission computed tomography with technetium 99m-labeled tetrofosmin: Influence of washout kinetics on regional myocardial uptake values of the rest study with a 1-day protocol

Journal of Nuclear Cardiology

Volumn 4, Issue 4, 1997, Pages 298-301

  Schulz, Gernot ^a,b   Ostwald, Elisabeth ^a   Kaiser, Hans J ^a   Vom Dahl, Jürgen ^a   Kleinhans, Eduard ^a   Buell, Udalrich ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Coronary artery disease; Emission computed tomography; Myocardial scintigraphy; Technetium 99m labeled tetrofosmin; Washout kinetics

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORONARY ARTERY DISEASE; EXERCISE TEST; FEMALE; HEART PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0030760658     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(97)90107-0     Document Type: Article

References (19)

1. Buell U, Kaiser HJ, Dupont F, Vebis R, Kleinhans E, Reske SN, et al. Methoxyisobutylisonitrile (MIBI) Tc 99m SPECT to establish a correlate to coronary flow reserve, the perfusion reserve, from global and regional myocardial uptake after exercise and rest. Eur J Nucl Med 1990;16:3-9.
2. 99mTc-methoxy-isobutyl-isonitrile SPECT to evaluate a perfusion index from regional myocardial uptake after exercise and at rest: results of a four hour protocol in patients with coronary heart disease and in controls. Nucl Med Commun 1990;11:77-94.
3. 201Tl with SPECT. Nucl Med Commun 1988;9:15-23.
4. Kelly JD, Forster AM, Highley B, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-7.
5. Sinusas AJ, Shi QX, Salzberg MT, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35: 664-71.
6. Highley B, Smith F, Smith T, et al. Technetium-99m-1,2bis[bis(2-ethoxyethyl)phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.
7. Jain D, Wackers FTH, Mattera J, et al. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993;34:1254-9.
8. Sridhara BS, Braat S, Rigo P, et al. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993;72: 1015-9.
9. Hönl K, Bentrup A, Pethe A, Otto HJ, Klein H. Myokardszintigraphie mit Tc-99m-Tetrofosmin: Bestimmung der myokardialen Halbwertszeit zur Optimierung des Studienprotokolls [abstract]. Nuklearmedizin 1996;35:A67.
10. Laubenbacher C, Rothley J, Sitomer J, et al. An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med 1993;34:969-78.
11. Jones S, Hendel RC. Technetium-99m tetrofosmin: a new myocardial perfusion agent. J Nucl Med Technol 1993;21:191-5.
12. Okada RD, Glover DK, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988;77:491-8.
13. Glover DK, Okada RD. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation 1990;81:628-36.
14. Maurea S, Cuocolo A, Soricelli A, Castelli L, Squame F, Imbriaco M, et al. Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med 1995;36:1953-60.
15. Kao CH, Wang SJ, Ting CT, Chen YT. 'Reverse redistribution pattern' during myocardial perfusion imaging with 99mTc-MIBI. Nucl Med Commun 1996;17:397-9.
16. 201Tl: implications of early post stress kinetics. Nucl Med Commun 1996;17:400-9.
17. Yong ATK, Chambers J, Maisey MN, Fogelmann I, Clarke SEM. Technetium-99m tetrofosmin myocardial perfusion scan: comparison of 1-day and 2-day protocols. Eur J Nucl Med 1996;23:320-5.
18. Rigo P, Leclercq B, Itti R, Lahiri A, Brat S. Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994;35:587-93.
19. 201Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995;91:313-9.